Home
About us
Annual Meeting Abstracts
Annual Meeting
Annual Meeting

Annual Meeting Abstracts

22nd Annual Meeting of the Japanese Society of Clinical Neuropsychopharmacology
jointly with 42nd Annual Meeting of Japanese Society of Newropsychopharmacology

October 18-20, 2012
Tochigi prefectural General Culture Center,
Utsunomiya Hotel Grande, Utsunomiya Japan

FIRST AUTHOR INDEX
Last Name First Name No. Title
Lerer Bernard SL-1 Schizophrenia, impaired reality testing and the AHI1 gene: From men to mice
Lee Min-Soo SL-2 Advances of pharmacogenetics in psychiatry
Kennedy Sidney H. CL-1 Measurement in clinical trials: Right scales for the right patients
TAKARADA TAKESHI S11-1 NMDA receptor and uncoupling protein
FURUKAWA TOSHIAKI S12-2 Strategic use of new generation antidepressants for depression
NAKAMURA MITSUHIRO EN-1 Mortality of neuroleptic malignant syndrome induced by typical and atypical antipsychotic drugs:A propensity-matched analysis from the japanese diagnosis procedure combination database
SUGAI TAKURO EN-2 Excessive insulin secretion in Japanese schizophrenic patients treated with antipsychotics, despite normal fasting glucose levels
SUZUKI TAKEFUMI AB My 2-year clinical experiences in Toronto
Lerer Bernard LS2-A Parallels and contrasts in the genetics and psychopharmacology of schizophrenia and bipolar disorder
Lee Min-Soo LS2-B New alternative to depression based on epidemiology and treatment of depression in Korea
Serretti Alessandro LS3-A What shall we know for more appropriate use of antidepressant drugs? Lessons from pharmacology and genetics of SSRI
Keck Paul LS3-B Evidence-based treatment of bipolar mania
Kennedy Sidney H. EV2-C Duloxetine: Update in effi cacy and effectiveness
WATANABE TAKASHI O1-F4 Serotonin transporter gene-linked polymorphic region infl uences discontinuation of pharmacotherapy with paroxetine in panic disorder
TANI HIDEAKI O1-D-11 Interventions to Reduce Antipsychotic Polypharmacy: A Systematic Review
MORIGUCHI SHO O1-D-15 D2 Receptor Occupancy and Remission in Schizophrenia: Analysis of the CATIE
SAKURAI HITOSHI O1-F-10 Trajectories of Individual Symptoms in Remitters versus Non-Remitters with Depression
HIRANO JINICHI O1-F-12 Adjunctive acetaminophen therapy for major depression: a preliminary report
SUGAI TAKURO O2-B-2 The effect of antipsychotics on insulin secretion
KOSHIBA MAMIKO O2-F-9 The support effect of antioxidant dietary supplement in elderly social psychology and immune system for preventive medicine
MORIGUCHI SHIGEKI O3-C-9 Activation of T-type voltage-dependent calcium channel on cognitive function
Siu Cynthia P1-7 Bayesian Predictive Power Analysis for Adaptive Trial Design and Phase II Dose-finding Strategies
TAKEKITA YOSHITERU P1-10 Relationship of DRD2 Taq1A polymorphism with perospirone and aripiprazole effi cacy in Japanese schizophrenia patients
KATO MASAKI P1-11 5-HTTLPR rs25531A>G differentially influence paroxetine and fluvoxamineantidepressant effi cacy: A randomized-controlled trial
KATO MASAKI P1-45 Long-Term Treatment with Lurasidone in Schizophrenia: Results of an 8-week Double-blind Acute Study Followed by a 44-Week Open-Label Extension
SUZUKI YUTARO P1-49 QT prolongation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite paliperidone
YAMAMOTO NOBUTOMO P2-1 The inter-rater reliability of the Structured interview guide for the Hamilton anxiety rating scale (SIGH-A) of the Japanese version
OHI KAZUTAKA P2-12 The p250GAP Gene is Associated with Risk for Schizophrenia and Schizotypal Personality Trait
TADORI YOSHIHIRO P2-25 Functional potencies of dopamine agonists and antagonists at human dopamine D2 and D3 receptors
YU ZHIQIAN P2-37 Therapeutic concentration of lithium stimulates immune related gene expressions in differentiated monocytic cells
NONAKA AYAKO P2-50 Diphenhydramine but not levocetirizine or olopatadine impairs consolidation and expression of conditioned fear
YAMADA SHINNOSUKE P2-56 Follistatin like-1 involves in polyI:C-induced impairment of neurite outgrowth
MAGARA SHIORI P2-59 Cytoprotective effects of sigma 1 receptor chaperone at mitochondria
NAKAMURA KYOKO P2-64 Effects of single and repeated electroconvulsive seizure on hippocampal cell proliferation and spontaneous and cognitive behaviors in the rats


Jscnp Japanese